These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 38018962)

  • 1. Repurposing a human acetyl-CoA carboxylase inhibitor firsocostat to treat fungal candidiasis alone and in combination.
    Chen T; Yao J; Quan K; Xu J; Hang X; Tong Q; Liu G; Luo P; Zeng L; Feng G; Bi H
    Antimicrob Agents Chemother; 2024 Jan; 68(1):e0113123. PubMed ID: 38018962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The anti-staphylococcal fusidic acid as an efflux pump inhibitor combined with fluconazole against vaginal candidiasis in mouse model.
    Gomaa SE; Abbas HA; Mohamed FA; Ali MAM; Ibrahim TM; Abdel Halim AS; Alghamdi MA; Mansour B; Chaudhary AA; Elkelish A; Boufahja F; Hegazy WAH; Yehia FAA
    BMC Microbiol; 2024 Feb; 24(1):54. PubMed ID: 38341568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology and Antifungal Susceptibility of
    Badiee P; Boekhout T; Haddadi P; Mohammadi R; Ghadimi-Moghadam A; Soltani J; Zarei Mahmoudabadi A; Ayatollahi Mousavi SA; Najafzadeh MJ; Diba K; Salimi-Khorashad AR; Amin Shahidi M; Ghasemi F; Jafarian H
    Microbiol Spectr; 2022 Dec; 10(6):e0245322. PubMed ID: 36445122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pore-forming peptide C14R exhibits potent antifungal activity against clinical isolates of
    Vélez N; Argel A; Kissmann AK; Alpízar-Pedraza D; Escandón P; Rosenau F; Ständker L; Firacative C
    Front Cell Infect Microbiol; 2024; 14():1389020. PubMed ID: 38601736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic potential of teriflunomide with fluconazole against resistant
    Li X; Kong B; Sun Y; Sun F; Yang H; Zheng S
    Front Cell Infect Microbiol; 2023; 13():1282320. PubMed ID: 38169891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo antifungal activities of FX0685, a novel triazole antifungal agent with potent activity against fluconazole-resistant Candida albicans.
    Takahata S; Okutomi T; Ohtsuka K; Hoshiko S; Uchida K; Yamaguchi H
    Med Mycol; 2005 May; 43(3):227-33. PubMed ID: 16010849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro susceptibility of Candida albicans clinical isolates to eight antifungal agents in Ouagadougou (Burkina Faso).
    Zida A; Yacouba A; Bamba S; Sangare I; Sawadogo M; Guiguemde T; Kone S; Traore LK; Ouedraogo-Traore R; Guiguemde RT
    J Mycol Med; 2017 Dec; 27(4):469-475. PubMed ID: 28754462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [INVESTIGATION ON ANTIFUNGAL SUSCEPTIBILITY OF CANDIDA YEASTS IN PREGNANT PATIENTS WITH CONFIRMED VULVOVAGINAL CANDIDIASIS AND THEIR NEWBORNS.].
    Chokoeva A; Kouzmanov A; Ivanova Z; Zisova L; Amalie G; Petleshkova P; Miteva-Katrandzhieva T; Krasteva M; Uchikova E
    Akush Ginekol (Sofiia); 2016; 55(4):20-29. PubMed ID: 29370489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic effect of eravacycline combined with fluconazole against resistant Candida albicans in vitro and in vivo.
    Li X; Yang H; Duan X; Cui M; Xing W; Zheng S
    Expert Rev Anti Infect Ther; 2023; 21(11):1259-1267. PubMed ID: 37818633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Riboflavin Targets the Cellular Metabolic and Ribosomal Pathways of Candida albicans
    Lei J; Huang J; Xin C; Liu F; Zhang J; Xie Y; Mao Y; Chen W; Song Z
    Microbiol Spectr; 2023 Feb; 11(1):e0380122. PubMed ID: 36625571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In-vitro evaluation of virulence markers and antifungal resistance of clinical Candida albicans strains isolated from Karachi, Pakistan.
    Jabeen G; Naz SA; Rangel DEN; Jabeen N; Shafique M; Yasmeen K
    Fungal Biol; 2023; 127(7-8):1241-1249. PubMed ID: 37495314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vulvovaginal candidiasis: species distribution of Candida and their antifungal susceptibility pattern.
    Bitew A; Abebaw Y
    BMC Womens Health; 2018 Jun; 18(1):94. PubMed ID: 29902998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repurposing of Ribavirin as an Adjunct Therapy against Invasive
    Yousfi H; Cassagne C; Ranque S; Rolain JM; Bittar F
    Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31307986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iranian HIV/AIDS patients with oropharyngeal candidiasis: identification, prevalence and antifungal susceptibility of Candida species.
    Khedri S; Santos ALS; Roudbary M; Hadighi R; Falahati M; Farahyar S; Khoshmirsafa M; Kalantari S
    Lett Appl Microbiol; 2018 Oct; 67(4):392-399. PubMed ID: 30019443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of Ginkgolide B combined with fluconazole against drug-resistant Candida albicans based on common resistance mechanisms.
    Li Y; Yang J; Li X; Su S; Chen X; Sun S; Li Y
    Int J Antimicrob Agents; 2020 Aug; 56(2):106030. PubMed ID: 32454072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Artemisinin elevates ergosterol levels of Candida albicans to synergise with amphotericin B against oral candidiasis.
    Zhu C; Liao B; Ye X; Zhou Y; Chen X; Liao M; Cheng L; Zhou X; Ren B
    Int J Antimicrob Agents; 2021 Sep; 58(3):106394. PubMed ID: 34197906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increasing Susceptibility of Drug-Resistant
    Sharafutdinov IS; Ozhegov GD; Sabirova AE; Novikova VV; Lisovskaya SA; Khabibrakhmanova AM; Kurbangalieva AR; Bogachev MI; Kayumov AR
    Molecules; 2020 Feb; 25(3):. PubMed ID: 32024254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of action of antimicrobial peptides ToAP2 and NDBP-5.7 against Candida albicans planktonic and biofilm cells.
    do Nascimento Dias J; de Souza Silva C; de Araújo AR; Souza JMT; de Holanda Veloso Júnior PH; Cabral WF; da Glória da Silva M; Eaton P; de Souza de Almeida Leite JR; Nicola AM; Albuquerque P; Silva-Pereira I
    Sci Rep; 2020 Jun; 10(1):10327. PubMed ID: 32587287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Galleria mellonella as an alternative in vivo model to study implant-associated fungal infections.
    Mannala GK; Rupp M; Walter N; Scholz KJ; Simon M; Riool M; Alt V
    J Orthop Res; 2023 Nov; 41(11):2547-2559. PubMed ID: 37080929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo analysis of monotherapy and dual therapy with ethyl caffeate and fluconazole on virulence factors of Candida albicans and systemic candidiasis.
    Wang T; Pan M; Xiao N; Wu J; Wang Q; Cheng T; Yan G; Wu D; Li N; Shao J
    J Glob Antimicrob Resist; 2021 Dec; 27():253-266. PubMed ID: 34700054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.